Castello-Pons, M., Ramirez-Gonzalez, M. A., Iglesias-Hernández, P., Lendo, N. L., Rodriguez-Martín, C., Quiralte, L., . . . Casas-Tinto, S. (2025). VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context.
Citación estilo ChicagoCastello-Pons, Maria, et al. VP3.15, a Dual GSK-3β/PDE7 Inhibitor, Reduces Glioblastoma Tumor Growth Though Changes in the Tumor Microenvironment in a PTEN Wild-type Context. 2025.
Cita MLACastello-Pons, Maria, et al. VP3.15, a Dual GSK-3β/PDE7 Inhibitor, Reduces Glioblastoma Tumor Growth Though Changes in the Tumor Microenvironment in a PTEN Wild-type Context. 2025.
Precaución: Estas citas no son 100% exactas.